Pharmacogenetic testing shows promise improving symptoms in patients with treatment-resistant depression — ScienceDaily

Via Peters

Pharmacogenetic testing was associated with nearly a two-fold (89 per cent) increase in remission rates compared to treatment as usual in a Centre for Addiction and Mental Health- (CAMH-)led clinical study just published in the journal Translational Psychiatry. The 52-week double-blind study, comparing pharmacogenetic testing guided treatment to treatment as […]

Improving Depression Symptoms: Study Meets Endpoints

Via Peters

A new study showed zuranolone treatment in patients with major depressive disorder demonstrates a rapid and statistically significant reduction in depressive symptoms. Sage Therapeutics and Biogen recently announced the CORAL Study examining zuranolone treatment in patients with major depressive disorder (MDD) demonstrated a rapid and statistically significant reduction in depressive […]